cbdMD Inc. (NYSE: YCBD) has had a decent head start in sorting itself out. The company can rest in the fact that it's become the closest thing to a "household name" in the cannabis industry nationwide.
A variety of products such as gummies, bath bombs, creams capsules, and tinctures has helped cbdMD penetrate a variety of markets. The company even has partnerships with several professional athletes promoting CBD for recovery purposes – Olympian Kerri Walsh Jennings, former NFL receiver Steve Smith, and Golfer Bubba Watso, to name a few.
While cbdMD is not yet profitable, they're cutting costs fast. They lost $2.54 per share in 2019, but analysts forecast a loss of only $0.43 per share in 2020. By 2021, the company plans to have a $0.33 profit per share.
Shares currently trade for Just $0.66. It's down with the broader market right now. But as the viral outbreak clears up, the lowest analyst growth target is $1.20. That's an 81% target.
But you may not even have to wait. People might be even more inclined to buy CBD products to calm anxiety while their cities are locked down.
So don't count this one out. The average analyst gives it a price target of $5.07, which is a profit of more than 600%.
Market Data 
Markets 
